Purna AI

What Purna AI does

Purna AI (legally Purna Biotech Lifesciences Private Limited) is an India-incorporated, Gurugram-headquartered life-sciences-AI company building the Molecular Intelligence Platform (MIP), a unified research workspace for biology R&D. The platform combines Deep Research (a knowledge engine searching 40+ high-authority biological databases and 400M+ research articles via a 25M-node Purna Knowledge Graph), Jobs (autonomous multi-step bioinformatics pipeline execution with code/figure/table outputs), BioLM Jobs (biological language-model workflows integrating ESM-2, AbLang, Boltz-2, and RFdiffusion for protein, antibody, and structure research), Consillium (a multi-agent hypothesis-debate system assembling specialist biological personas), Scribe Lab (scientific writing with citations and biological figure generation), Files (project file management with provenance), and a Genomic Workbench sub-product for enterprise clinical variant interpretation with ACMG/AMP classification.

The company serves four primary vertical segments—academic and research institutions, clinical genomics and diagnostic laboratories, drug discovery and biotech, and disease-focused research teams—via a product-led, self-serve free + Individual ($20/mo) + Pro ($90/mo) flow, a Team tier at $400/month for five users, and a custom Enterprise tier sold through Book-a-Demo CTAs. Revenue mechanics combine tiered subscriptions, usage-based AI credits, and a Research Credits Program offering up to $10,000 in free credits to qualifying academic/independent research teams; distribution is direct-only (self-serve web at mip.purna.ai, enterprise field sales, and clinical partnerships), with no marketplace or reseller channels disclosed.

Founded in 2025 by Siddhant Minocha (Co-Founder & CEO) and Dr. Gitanjali Ramchandani (Co-Founder & CMO), Purna AI operates with a 1–10-person team, uses Google Cloud Platform and Vercel as core infrastructure, holds HIPAA-availability and is actively pursuing SOC 2 Type II and ISO 27001 certification, and claims GDPR and CCPA compliance. The company is privately held with a single disclosed non-equity/undisclosed-value BIGShift partnership dated August 2025 and no disclosed priced equity round, ARR/revenue, patents, or third-party AI benchmarks in the source material.

Name

Purna AI

Legal name

Purna Biotech Lifesciences Private Limited

Website

https://purna.ai

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Purna AI builds a Molecular Intelligence Platform that unifies AI literature synthesis, autonomous bioinformatics pipelines, biological language-model execution, and scientific writing for academic researchers, clinical genomics teams, and drug-discovery scientists.

Ownership category

akta.pro rank

Product category

Bioinformatics and Life Sciences Research Software

NAICS

Software Publishers (5132), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design and Related Services (5415)

SIC

Services-Computer Integrated Systems Design (7373), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Model Hosting, Serving & Inference Platforms (HDAAACAB)

Keywords

• Bioinformatics software
• Life sciences AI
• Genomics research platform
• Multi-omics analysis
• Scientific writing tools

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Subscription Plans: Monthly and annual subscription tiers (Free, Individual $20/month, Pro $90/month) with AI credits, rate limits, compute time, and storage allocations. Annual plans save 17%.
2. Team & Enterprise Plans: Team pricing at $400/month for 5 users ($80/user) with 125K credits, 500h compute, 500GB storage. Enterprise custom pricing with dedicated account manager and custom infrastructure.
3. Usage-Based Consumption: AI credits as usage-based currency covering all AI interactions including queries and responses. Higher tiers provide more credits (5k Free, 20k Individual, 50k Pro).
4. Research Credits Program: Free credits program for qualifying academic and research teams, offering up to $10,000 in platform credits for multi-omics research teams as customer acquisition and adoption strategy.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Purna AI develops and sells the Molecular Intelligence Platform (MIP), a unified AI-powered workspace for life sciences research. It combines a knowledge engine for searching 50+ biological databases and 400M+ research articles, autonomous bioinformatics workflow execution, biological language model runs (ESM-2, AbLang, Boltz-2, RFdiffusion), multi-agent hypothesis reasoning, and a scientific writing workspace in a single connected environment. It is offered via subscription tiers (Free, Individual, Pro, Team) and custom Enterprise pricing, including a specialized Genomic Workbench for clinical variant interpretation.

Product overview

Purna AI's Molecular Intelligence Platform (MIP) is a unified AI-powered research workspace for life sciences R&D. The platform consists of a core Molecular Intelligence Platform that unifies Deep Research (knowledge engine searching 40+ biological databases), Scribe Lab (scientific writing workspace), Jobs (computational bioinformatics execution), BioLM Jobs (biological model workflows for protein/antibody/structure), Consillium (multi-agent hypothesis debate), and Files (project file management). A specialized sub-product, the Genomic Workbench, provides enterprise clinical genomics capabilities for variant interpretation with ACMG/AMP classification. The platform targets academic research, disease research, drug discovery, genomics, and multi-omics workflows across individual, team, and enterprise plans.

Differentiator

Problem solved

Functional benefit

Brands

• Molecular Intelligence Platform (MIP): AI-powered workspace for life sciences research including deep research, bioinformatics workflows, and scientific writing.
• Genomic Workbench
• Scribe Lab

Products and services

• Molecular Intelligence Platform (MIP) Unified AI-powered research workspace for life sciences R&D that conducts deep research across biological databases, runs multi-omics and bioinformatics workflows, executes biological language model jobs, debates hypotheses via multi-agent reasoning, and supports scientific writing. Targeted at academic research, disease research, drug discovery, genomics, and multi-omics teams across individual, team, and enterprise plans.
• Deep Research Knowledge engine that searches 40+ high-authority biological databases (PubMed, ClinVar, KEGG, UniProt, Reactome, gnomAD), reasons with the Purna Graph knowledgebase, and produces citation-backed research synthesis connecting literature, genes, pathways, variants, compounds, and biological context. Used by life sciences researchers for literature synthesis and evidence review.
• Scribe Lab Scientific writing workspace with full editor workflow, AI copilot for drafts, multi-user review and comments, citations management, and biological illustration generation. Connects writing to evidence, figures, and analysis outputs. Targeted at academic and research teams producing scientific manuscripts.
• BioLM Jobs Biological language model workflows for sequence, protein, antibody, and structure research. Runs models including ESM-2, AbLang, Boltz-2, and RFdiffusion without separate model deployment. Maps biological goals to model workflows and executes managed compute with output capture. Used by drug discovery and protein design researchers.
• Consillium Multi-agent reasoning platform that assembles specialist AI agents (molecular biologist, structural biologist, geneticist, virologist, devil's advocate) to argue, challenge, and refine biological hypotheses. Surfaces contradictions, missing controls, alternative mechanisms, and produces consensus points with next-step experiments. Targeted at disease and drug discovery research teams.
• Genomic Workbench Enterprise-grade clinical genomics platform for variant interpretation, going from VCF to signed report with ACMG/AMP-aligned variant classification, CNV detection, AI-drafted interpretations, gene panel management, team workflows with role-based access, SSO, SOC 2-ready infrastructure, and full audit trails. Targeted at clinical genomics and diagnostic labs.

Quantifiable outcome

• Deep Research Mode plans, searches, compares, cites, and synthesizes evidence with traceable citations
• +2 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature8 records

Partnerships

Two partnerships are on record, tiered core infrastructure.

• Google Cloud Platformcore infrastructureTechnology or IntegrationPrimary cloud infrastructure provider for the Molecular Intelligence Platform. Handles data storage and processing with encryption at rest (AES-256) and in transit. Data centers located in India and the United States.
• Vercelcore infrastructureTechnology or IntegrationFrontend deployment and hosting platform for the web application. Part of the cloud infrastructure stack alongside Google Cloud Platform.

Scale indicators4 records

Recent moves6 records

Expansion highlights8 records

Emerging players

• Owkin: Owkin applies AI to biomedical and clinical research data for drug discovery and patient stratification, comparable to Purna's disease research and clinical genomics positioning around multi-omics and AI-driven hypothesis generation.
• Elicit: Elicit is an AI research assistant that searches and synthesizes scientific literature with citations, comparable to Purna's Deep Research and Scribe Lab features for academic and life-sciences research workflows.
• Insitro: Insitro applies ML to biological data for drug discovery, overlapping with Purna's drug discovery and BioLM Jobs use cases around target identification, pathway reasoning, and computational biology.
• Recursion: Recursion combines high-throughput biology with AI/ML models for drug discovery, comparable to Purna's Consillium and BioLM Jobs in the AI-for-biology and computational drug discovery space.

Direct peers

• Benchling: Benchling is the dominant cloud ELN/LIMS and R&D data platform for life sciences, competing head-on with Purna's Molecular Intelligence Platform for ownership of biologists' daily workflows in academia, biotech, and pharma.
• DNAnexus: DNAnexus provides a cloud genomics data and analysis platform with clinical-grade variant interpretation and audit trails, directly comparable to Purna's Genomic Workbench for clinical genomics and multi-omics customers.
• BioRender: BioRender provides a scientific figure and illustration workspace used by biologists and medical researchers, overlapping with Scribe Lab's biological illustrations and publication-quality figure generation features.

Broad incumbents

• Semantic Scholar: Semantic Scholar (Allen AI) provides AI-powered scientific literature search and APIs used by researchers, overlapping with Purna's Deep Research literature-synthesis capability at the discovery and citation layer.
• TetraScience: TetraScience is a scientific data cloud for life sciences R&D, comparable in its ambition to be the unified data and integration layer for biologists — a layer Purna is targeting via Files and the Purna Knowledge Graph.
• Elsevier Reaxys: Reaxys is Elsevier's chemistry and life-sciences literature and database search platform, comparable to Purna's Deep Research querying of curated biological databases (PubMed, ClinVar, KEGG, UniProt, etc.) for evidence-backed research synthesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sidwantscoffee
• YouTubeyoutube.com/@purna_bio
• LinkedInlinkedin.com/company/purnahealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Purna AI